Open Access

Symposium on Recent Novel Therapies in the Treatment of Acute Coronary Syndromes

  • Giuseppe Nattino
Critical Care19993:webreport10

DOI: 10.1186/ccf-1999-webreport10

Published: 21 May 1999

Overview

A new symposium has recently been added at the site, entitled 'Recent Novel Therapies in the Treatment of Acute Coronary Syndromes'. Presented as a satellite symposium on Saturday 6 March 1999 at the 1999 American College of Cardiology meeting, this symposium presented new information on the use of ion pumpinhibitors and thrombolytics in the management of cardiovascular disease.

The faculty and topics included:

Robert Roberts, MD, Program Chairman

Metin Avkiran, PhD: Scientific basis of NHE in acute cardiac ischemia

John Speer Schroeder, MD: Clinical potential of NHE inhibition - the GUARDIAN trial

Pierre Theroux, MD, Program Co-Chairman: Panel discussion/Question and answers

Hirudin is superior to heparin in acute coronary syndromes

Point: James H Chesebro, MD

Counterpoint: Robert M Califf, MD

Transcription-only and Multimedia (RealPlayer® technology required) versionsare available both providing the full slide show and the text of the presentations.

Other comments

March 1999.

Evaluation

None.

References

  1. Medical Matrix Symposia on the Web. [http://www.medmatrix.org/symposia]

Copyright

© Current Science Ltd 1999

Advertisement